nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzphetamine—SLC6A3—Clearance of dopamine—COMT—conduct disorder	0.124	0.138	CbGpPWpGaD
Benzphetamine—SLC6A3—Clearance of dopamine—MAOA—conduct disorder	0.123	0.137	CbGpPWpGaD
Benzphetamine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.0564	0.0629	CbGpPWpGaD
Benzphetamine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.056	0.0624	CbGpPWpGaD
Benzphetamine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.0542	0.0605	CbGpPWpGaD
Benzphetamine—SLC18A2—Norepinephrine Neurotransmitter Release Cycle—MAOA—conduct disorder	0.0491	0.0548	CbGpPWpGaD
Benzphetamine—SLC18A2—Synaptic Vesicle Pathway—SLC6A4—conduct disorder	0.0283	0.0316	CbGpPWpGaD
Benzphetamine—SLC6A2—Monoamine Transport—SLC6A4—conduct disorder	0.0277	0.0309	CbGpPWpGaD
Benzphetamine—Pargyline—MAOA—conduct disorder	0.0255	0.246	CrCbGaD
Benzphetamine—SLC18A2—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.0249	0.0278	CbGpPWpGaD
Benzphetamine—SLC6A3—Monoamine Transport—SLC6A4—conduct disorder	0.0245	0.0274	CbGpPWpGaD
Benzphetamine—ADRA1A—Monoamine GPCRs—DRD4—conduct disorder	0.0174	0.0194	CbGpPWpGaD
Benzphetamine—ADRA2A—Monoamine GPCRs—DRD4—conduct disorder	0.0162	0.0181	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.015	0.0167	CbGpPWpGaD
Benzphetamine—ADRA1A—Amine ligand-binding receptors—DRD4—conduct disorder	0.0146	0.0163	CbGpPWpGaD
Benzphetamine—ADRA2A—Amine ligand-binding receptors—DRD4—conduct disorder	0.0136	0.0152	CbGpPWpGaD
Benzphetamine—Selegiline—MAOA—conduct disorder	0.0128	0.123	CrCbGaD
Benzphetamine—SLC18A2—Neuronal System—GABRA2—conduct disorder	0.0115	0.0128	CbGpPWpGaD
Benzphetamine—ADRA1A—Monoamine GPCRs—HTR2A—conduct disorder	0.0114	0.0127	CbGpPWpGaD
Benzphetamine—ADRA2A—Monoamine GPCRs—HTR2A—conduct disorder	0.0106	0.0118	CbGpPWpGaD
Benzphetamine—Methamphetamine—MAOA—conduct disorder	0.00983	0.0946	CrCbGaD
Benzphetamine—ADRA1A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00955	0.0107	CbGpPWpGaD
Benzphetamine—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.00902	0.0101	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00892	0.00995	CbGpPWpGaD
Benzphetamine—ADRA2A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00887	0.0099	CbGpPWpGaD
Benzphetamine—SLC6A2—NRF2 pathway—SLC6A4—conduct disorder	0.00822	0.00918	CbGpPWpGaD
Benzphetamine—Cyclobenzaprine—HTR2A—conduct disorder	0.00816	0.0785	CrCbGaD
Benzphetamine—SLC6A3—NRF2 pathway—SLC6A4—conduct disorder	0.00728	0.00813	CbGpPWpGaD
Benzphetamine—Promazine—DRD4—conduct disorder	0.00724	0.0697	CrCbGaD
Benzphetamine—SLC18A2—Transmission across Chemical Synapses—COMT—conduct disorder	0.0072	0.00803	CbGpPWpGaD
Benzphetamine—SLC18A2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00715	0.00798	CbGpPWpGaD
Benzphetamine—Amphetamine—SLC6A4—conduct disorder	0.00684	0.0658	CrCbGaD
Benzphetamine—SLC6A3—Neuronal System—GABRA2—conduct disorder	0.00683	0.00762	CbGpPWpGaD
Benzphetamine—Methamphetamine—SLC6A4—conduct disorder	0.00634	0.061	CrCbGaD
Benzphetamine—Atomoxetine—SLC6A4—conduct disorder	0.00624	0.06	CrCbGaD
Benzphetamine—SLC18A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00616	0.00688	CbGpPWpGaD
Benzphetamine—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0061	0.00681	CbGpPWpGaD
Benzphetamine—SLC18A2—Neuronal System—COMT—conduct disorder	0.00552	0.00616	CbGpPWpGaD
Benzphetamine—SLC18A2—Neuronal System—MAOA—conduct disorder	0.00548	0.00611	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00514	0.00574	CbGpPWpGaD
Benzphetamine—Trimipramine—SLC6A4—conduct disorder	0.00513	0.0493	CrCbGaD
Benzphetamine—Atomoxetine—HTR2A—conduct disorder	0.00479	0.0461	CrCbGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00478	0.00533	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—COMT—conduct disorder	0.00429	0.00479	CbGpPWpGaD
Benzphetamine—SLC6A3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00426	0.00476	CbGpPWpGaD
Benzphetamine—SLC6A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00415	0.00463	CbGpPWpGaD
Benzphetamine—Trimipramine—HTR2A—conduct disorder	0.00394	0.0379	CrCbGaD
Benzphetamine—ADRA1A—GPCR ligand binding—CGA—conduct disorder	0.00391	0.00437	CbGpPWpGaD
Benzphetamine—Promethazine—HTR2A—conduct disorder	0.0038	0.0365	CrCbGaD
Benzphetamine—SLC6A3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00367	0.0041	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—CGA—conduct disorder	0.00364	0.00406	CbGpPWpGaD
Benzphetamine—ADRA2A—G alpha (i) signalling events—DRD4—conduct disorder	0.00336	0.00375	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00336	0.00375	CbGpPWpGaD
Benzphetamine—Promazine—HTR2A—conduct disorder	0.00334	0.0321	CrCbGaD
Benzphetamine—SLC6A3—Neuronal System—COMT—conduct disorder	0.00329	0.00367	CbGpPWpGaD
Benzphetamine—SLC6A3—Neuronal System—MAOA—conduct disorder	0.00326	0.00364	CbGpPWpGaD
Benzphetamine—CYP2B6—Biological oxidations—COMT—conduct disorder	0.00326	0.00364	CbGpPWpGaD
Benzphetamine—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.00324	0.00362	CbGpPWpGaD
Benzphetamine—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.00322	0.00359	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00312	0.00348	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00288	0.00321	CbGpPWpGaD
Benzphetamine—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.00284	0.00316	CbGpPWpGaD
Benzphetamine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00277	0.00309	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00267	0.00298	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00254	0.00283	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	0.00221	0.00247	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00219	0.00245	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	0.00219	0.00245	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	0.00206	0.00229	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00204	0.00227	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	0.00204	0.00227	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CGA—conduct disorder	0.00201	0.00224	CbGpPWpGaD
Benzphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00188	0.0021	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CGA—conduct disorder	0.00187	0.00208	CbGpPWpGaD
Benzphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00174	0.00195	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00148	0.00165	CbGpPWpGaD
Benzphetamine—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00147	0.00164	CbGpPWpGaD
Benzphetamine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00146	0.00163	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	0.00143	0.0016	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	0.00133	0.00148	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CGA—conduct disorder	0.00132	0.00147	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	0.00124	0.00138	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CGA—conduct disorder	0.00124	0.00138	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CGA—conduct disorder	0.00119	0.00132	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	0.00115	0.00128	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	0.00112	0.00126	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CGA—conduct disorder	0.0011	0.00123	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	0.00105	0.00117	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—WASF1—conduct disorder	0.000951	0.00106	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—WASF1—conduct disorder	0.000884	0.000986	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	0.000808	0.000902	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	0.000751	0.000838	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	0.000734	0.000819	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	0.000682	0.000761	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—DRD4—conduct disorder	0.000665	0.000742	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—EP300—conduct disorder	0.00063	0.000703	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—DRD4—conduct disorder	0.000617	0.000689	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—COMT—conduct disorder	0.000595	0.000664	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—MAOA—conduct disorder	0.000591	0.00066	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CGA—conduct disorder	0.000562	0.000627	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—COMT—conduct disorder	0.000558	0.000623	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—MAOA—conduct disorder	0.000554	0.000618	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	0.000434	0.000484	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	0.000403	0.00045	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—EP300—conduct disorder	0.000255	0.000285	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—COMT—conduct disorder	0.000254	0.000283	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—MAOA—conduct disorder	0.000252	0.000281	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—EP300—conduct disorder	0.000239	0.000267	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—EP300—conduct disorder	0.00023	0.000256	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—EP300—conduct disorder	0.000213	0.000238	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—EP300—conduct disorder	0.000109	0.000121	CbGpPWpGaD
